Pros and Cons of Nymox Pharmaceutical Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nymox Pharmaceutical Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Nymox Pharmaceutical Corp. | - | - | - | - | - | - | - |
Promis Neurosciences Inc. | -2.420% | 13.380% | -7.471% | -65.152% | 61.809% | -79.825% | -84.840% |
InMed Pharmaceuticals Inc. | 2.700% | -2.022% | 8.776% | -78.156% | -22.529% | -99.552% | -99.884% |
Resverlogix Corp | 10.610% | 0.000% | 0.000% | -51.007% | -15.116% | -93.917% | -98.355% |
Comments
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat